CTRI/2021/01/030477已完成未知
Study to Evaluate the Efficacy of Mycophenolate Sodium in Covid 19 Infection.
Shri Janai Research Foundation0 个研究点目标入组 212 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 212
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subjects with active COVID ââ?¬â?? 19 infection.
- •2. Age more than 18 years.
- •3. Actual or estimated weight more than 50kg.
- •4. Mild to moderate infection.
- •5. Subjects willing to give consent for participation in the study.
- •6. No clinical contraindications for Mycophenolate administration.
排除标准
- •1. Age less than 18 years.
- •2. Subjects not willing to give consent for participation in the study.
- •3. Subjects having pancytopenia.
- •4. Subjects with secondary bacterial sepsis.
- •5. Subjects already taking immunosuppressive medications for other conditions.
研究者
相似试验
进行中（未招募）
1 期
Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay immunosuppression in comparison to current standard immunosuppression (mycophenolate mofetil, tacrolimus and continued corticosteroids) in renal transplantation. - UK ELiTERenal TransplantationMedDRA version: 7.1Level: PTClassification code 10038533EUCTR2004-005055-33-GBBarts and the London NHS Trust
已完成
不适用
A Randomised Controlled Trial of Mycophenolate Mofetil (MMF) in Patients with Immunoglobulin A (IgA) Nephropathy (IgAN)IgA NephropathyUrological and Genital DiseasesISRCTN62574616Medical City Dallas Hospital (USA)100
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitisEUCTR2006-001663-33-DECambridge University Hospitals NHS Foundation Trust140
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitis. Wegener´s granulomatosis (WG) and microscopic polyangiitis (MPA) are primary systemic vasculitides associated with ANCAEUCTR2006-001663-33-SECambridge University Hospitals NHS Foundation Trust140
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis. - MYCYCPatient ayant une vascularite associée aux ANCAMedDRA version: 8.1Level: PTClassification code 10047115Term: VasculitisEUCTR2006-001663-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)140